BRCA genetic testing of individuals from families with low prevalence of cancer: experiences of carriers and implications for population screening : Genetics in Medicine : Nature Publishing Group
Purpose:
BRCA genes are associated with hereditary breast and ovarian cancers. Guidelines worldwide currently recommend BRCA genetic testing in asymptomatic individuals only if they belong to “high-risk” families. However, population screening for BRCA1/2
may be the logical next step in populations with a high prevalence of
founder mutations, such as Ashkenazi Jews. This study aimed to explore
(i) the impact of a positive BRCA genetic test result on
individuals who have neither a personal history nor a familial history
of cancer and (ii) their attitudes toward the concept of population
screening.
Methods:
Semistructured in-depth interviews were carried out with 14 Ashkenazi Jewish women who were asymptomatic BRCA carriers and who belonged to families with low prevalence of cancer.
Results:
Three main findings emerged: (i) having no family
history of cancer was a source of optimism but also confusion; (ii)
engaging in intensified medical surveillance and undergoing preventive
procedures was perceived as health-promoting but also tended to induce a
sense of physical and psychological vulnerability; and (iii) there was
overall support for BRCA population screening, with some reservations.
Conclusion:
Women belonging to low-cancer-prevalence families within a “high-risk” ethnic community view BRCA
genetic testing positively despite the difficulties entailed, because
it allows prevention or early detection of cancer. However, implementing
a BRCA population screening program should be carried out with
proper pre- and post-testing preparation and support for the individuals
undergoing testing.